Updated efficacy and safety of taletrectinib in patients ( pts) with ROS1+non-small cell lung cancer (NSCLC)-MedSci.cn

Updated efficacy and safety of taletrectinib in patients ( pts) with ROS1+non-small cell lung cancer (NSCLC)

Li, W; Yang, N; Li, K; Fan, H; Yu, Q; Wu, H; Wang, Y; Meng, X; Wu, J; Wang, Z; Liu, Y; Wang, X; Qin, X; Lu, K; Zhuang, W; He, S; Janne, PA; Seto, T; Ou, SHI; Zhou, C

JOURNAL OF THORACIC ONCOLOGY, 2023; 18 (4): S47

科室
- - 订阅+
  - 更多科室
工具
服务